GlassScriptPhysician profile
William V Burke
NPI 1407811524
$331,735.35
in general payments reported to CMS, 2019-2025
7 companies · $35K in 2025
The $35K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $21K · 2021: $81K · 2022: $52K · 2023: $62K · 2024: $28K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $60K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $18K · Consulting Fee: $9,933 · Food and Beverage: $3,601 · Education: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $59,836.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,237.28 |
| Travel and Lodging | $18,100.63 |
| Consulting Fee | $9,932.50 |
| Food and Beverage | $3,600.94 |
| Education | $2,233.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $217,862.18 | 2019-2025 | Mpo Medial Pivot Knee, Mpo Hip System |
| Zimmer Biomet Holdings, INC. | $86,617.74 | 2019-2025 | Arcos Revision Hip Instrumentation, Arcos, Persona |
| Uoc USA INC | $23,526.75 | 2023-2025 | Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee, Medial Pivot, U3 Medial Pivot |
| Encore Medical, LP | $2,649.06 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $625.60 | 2024 | Iovera |
| Medacta USA, INC. | $355.78 | 2020 | |
| Smith+Nephew, INC. | $98.24 | 2022-2025 | Legion Revision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.